{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T02:40:40Z","timestamp":1793328040572,"version":"4.5.0"},"publisher-location":"New York, NY","reference-count":24,"publisher":"Springer US","isbn-type":[{"value":"9781071627716","type":"print"},{"value":"9781071627723","type":"electronic"}],"license":[{"start":{"date-parts":[[2022,11,19]],"date-time":"2022-11-19T00:00:00Z","timestamp":1668816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,11,19]],"date-time":"2022-11-19T00:00:00Z","timestamp":1668816000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023]]},"DOI":"10.1007\/978-1-0716-2772-3_4","type":"book-chapter","created":{"date-parts":[[2022,11,18]],"date-time":"2022-11-18T18:07:03Z","timestamp":1668794823000},"page":"55-66","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Cardiac and Skeletal Muscle Pathology in the D2\/mdx Mouse Model and Caveats Associated with the Quantification of Utrophin"],"prefix":"10.1007","author":[{"given":"Tahnee L.","family":"Kennedy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah F.","family":"Dugdale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,19]]},"reference":[{"key":"4_CR1","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.omtm.2018.10.005","volume":"11","author":"TL Kennedy","year":"2018","unstructured":"Kennedy TL et al (2018) Micro-utrophin improves cardiac and skeletal muscle function of severely affected D2\/mdx mice. Mol Ther Methods Clin Dev 11:92\u2013105","journal-title":"Mol Ther Methods Clin Dev"},{"issue":"3","key":"4_CR2","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1002\/ana.23528","volume":"71","author":"JR Mendell","year":"2012","unstructured":"Mendell JR et al (2012) Evidence-based path to newborn screening for Duchenne muscular dystrophy. Ann Neurol 71(3):304\u2013313","journal-title":"Ann Neurol"},{"issue":"6","key":"4_CR3","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.nmd.2014.03.008","volume":"24","author":"JK Mah","year":"2014","unstructured":"Mah JK et al (2014) A systematic review and meta-analysis on the epidemiology of Duchenne and Becker muscular dystrophy. Neuromuscul Disord 24(6):482\u2013491","journal-title":"Neuromuscul Disord"},{"issue":"4","key":"4_CR4","doi-asserted-by":"publisher","first-page":"44","DOI":"10.3390\/jfmk2040044","volume":"2","author":"L Forcina","year":"2017","unstructured":"Forcina L et al (2017) Insights into the pathogenic secondary symptoms caused by the primary loss of dystrophin. J Funct Morphol Kinesiol 2(4):44","journal-title":"J Funct Morphol Kinesiol"},{"issue":"4","key":"4_CR5","first-page":"490","volume":"15","author":"S Head","year":"1994","unstructured":"Head S, Williams D, Stephenson G (1994) Increased susceptibility of EDL muscles from mdx mice to damage induced by contraction with stretch. J Muscle Res Cell Motil 15(4):490\u2013492","journal-title":"J Muscle Res Cell Motil"},{"issue":"2","key":"4_CR6","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1002\/mus.880100212","volume":"10","author":"JR Bach","year":"1987","unstructured":"Bach JR et al (1987) Management of end stage respiratory failure in Duchenne muscular dystrophy. Muscle Nerve 10(2):177\u2013182","journal-title":"Muscle Nerve"},{"issue":"2","key":"4_CR7","first-page":"118","volume":"5","author":"Y Rideau","year":"1983","unstructured":"Rideau Y et al (1983) Prolongation of life in Duchenne\u2019s muscular dystrophy. Acta Neurol 5(2):118\u2013124","journal-title":"Acta Neurol"},{"issue":"1","key":"4_CR8","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1002\/ppul.23215","volume":"51","author":"DJ Birnkrant","year":"2016","unstructured":"Birnkrant DJ, Ararat E, Mhanna MJ (2016) Cardiac phenotype determines survival in Duchenne muscular dystrophy. Pediatr Pulmonol 51(1):70\u201376","journal-title":"Pediatr Pulmonol"},{"issue":"6219","key":"4_CR9","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/339055a0","volume":"339","author":"DR Love","year":"1989","unstructured":"Love DR et al (1989) An autosomal transcript in skeletal muscle with homology to dystrophin. Nature 339(6219):55\u201358","journal-title":"Nature"},{"issue":"2","key":"4_CR10","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/S0165-3806(99)00165-0","volume":"119","author":"S Lin","year":"2000","unstructured":"Lin S, Burgunder J-M (2000) Utrophin may be a precursor of dystrophin during skeletal muscle development. Dev Brain Res 119(2):289\u2013295","journal-title":"Dev Brain Res"},{"issue":"12","key":"4_CR11","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1038\/4033","volume":"4","author":"J Tinsley","year":"1998","unstructured":"Tinsley J et al (1998) Expression of full-length utrophin prevents muscular dystrophy in mdx mice. Nat Med 4(12):1441\u20131444","journal-title":"Nat Med"},{"issue":"38","key":"4_CR12","doi-asserted-by":"publisher","first-page":"13856","DOI":"10.1073\/pnas.0405972101","volume":"101","author":"TO Krag","year":"2004","unstructured":"Krag TO et al (2004) Heregulin ameliorates the dystrophic phenotype in mdx mice. Proc Natl Acad Sci 101(38):13856\u201313860","journal-title":"Proc Natl Acad Sci"},{"key":"4_CR13","doi-asserted-by":"publisher","unstructured":"Tinsley JM et al (2011) Daily treatment with SMTC1100, a novel small molecule utrophin upregulator, dramatically reduces the dystrophic symptoms in the mdx mouse. PLoS One 6(5):e19189. https:\/\/doi.org\/10.1371\/journal.pone.0019189. PMID: 21573153; PMCID: PMC3089598","DOI":"10.1371\/journal.pone.0019189"},{"issue":"1","key":"4_CR14","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1093\/hmg\/ddv460","volume":"25","author":"WD Coley","year":"2016","unstructured":"Coley WD et al (2016) Effect of genetic background on the dystrophic phenotype in mdx mice. Hum Mol Genet 25(1):130\u2013145","journal-title":"Hum Mol Genet"},{"issue":"9","key":"4_CR15","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.1016\/j.ajpath.2017.05.010","volume":"187","author":"R Vohra","year":"2017","unstructured":"Vohra R et al (2017) Magnetic resonance monitoring of disease progression in mdx mice on different genetic backgrounds. Am J Pathol 187(9):2060\u20132070","journal-title":"Am J Pathol"},{"issue":"10","key":"4_CR16","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/S0828-282X(08)70686-X","volume":"24","author":"J Finsterer","year":"2008","unstructured":"Finsterer J, St\u00f6llberger C (2008) Cardiac involvement in Becker muscular dystrophy. Can J Cardiol 24(10):786\u2013792","journal-title":"Can J Cardiol"},{"issue":"7","key":"4_CR17","doi-asserted-by":"publisher","first-page":"8110","DOI":"10.1096\/fj.201802488R","volume":"33","author":"M van Putten","year":"2019","unstructured":"van Putten M et al (2019) Natural disease history of the D2-mdx mouse model for Duchenne muscular dystrophy. FASEB J 33(7):8110\u20138124","journal-title":"FASEB J"},{"issue":"5","key":"4_CR18","doi-asserted-by":"publisher","first-page":"2414","DOI":"10.2353\/ajpath.2010.090887","volume":"176","author":"S-I Fukada","year":"2010","unstructured":"Fukada S-I et al (2010) Genetic background affects properties of satellite cells and mdx phenotypes. Am J Pathol 176(5):2414\u20132424","journal-title":"Am J Pathol"},{"issue":"1","key":"4_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-020-70987-y","volume":"10","author":"DW Hammers","year":"2020","unstructured":"Hammers DW et al (2020) The D2. mdx mouse as a preclinical model of the skeletal muscle pathology associated with Duchenne muscular dystrophy. Sci Rep 10(1):1\u201312","journal-title":"Sci Rep"},{"issue":"1","key":"4_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep38371","volume":"6","author":"M Rodrigues","year":"2016","unstructured":"Rodrigues M et al (2016) Impaired regenerative capacity and lower revertant fibre expansion in dystrophin-deficient mdx muscles on DBA\/2 background. Sci Rep 6(1):1\u20139","journal-title":"Sci Rep"},{"issue":"6","key":"4_CR21","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1590\/S0100-879X2002000600009","volume":"35","author":"MA Luz","year":"2002","unstructured":"Luz MA, Marques MJ, Santo Neto H (2002) Impaired regeneration of dystrophin-deficient muscle fibers is caused by exhaustion of myogenic cells. Braz J Med Biol Res 35(6):691\u2013695","journal-title":"Braz J Med Biol Res"},{"issue":"8","key":"4_CR22","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1007\/BF02388063","volume":"25","author":"A Clerk","year":"1993","unstructured":"Clerk A et al (1993) Dystrophin-related protein, utrophin, in normal and dystrophic human fetal skeletal muscle. Histochem J 25(8):554\u2013561","journal-title":"Histochem J"},{"issue":"8","key":"4_CR23","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1097\/00005072-199808000-00007","volume":"57","author":"S Lin","year":"1998","unstructured":"Lin S, Gaschen F, Burgunder J-M (1998) Utrophin is a regeneration-associated protein transiently present at the sarcolemma of regenerating skeletal muscle fibers in dystrophin-deficient hypertrophic feline muscular dystrophy. J Neuropathol Exp Neurol 57(8):780\u2013790","journal-title":"J Neuropathol Exp Neurol"},{"key":"4_CR24","doi-asserted-by":"publisher","first-page":"45285","DOI":"10.1074\/jbc.M205177200","volume":"277","author":"AP Weir","year":"2002","unstructured":"Weir AP, Burton EA, Harrod G, Davies KE (2002) A- and B-utrophin have different expression patterns and are differentially up-regulated in mdx muscle*. J Biol Chem 277:45285\u201345290","journal-title":"J Biol Chem"}],"updated-by":[{"DOI":"10.1007\/978-1-0716-2772-3_31","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2023,3,2]],"date-time":"2023-03-02T00:00:00Z","timestamp":1677715200000}}],"container-title":["Methods in Molecular Biology","Muscular Dystrophy Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-2772-3_4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T07:07:19Z","timestamp":1677654439000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-2772-3_4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,19]]},"ISBN":["9781071627716","9781071627723"],"references-count":24,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-2772-3_4","relation":{"correction":[{"id-type":"doi","id":"10.1007\/978-1-0716-2772-3_31","asserted-by":"object"}]},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,19]]},"assertion":[{"value":"19 November 2022","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}},{"value":"2 March 2023","order":2,"name":"change_date","label":"Change Date","group":{"name":"ChapterHistory","label":"Chapter History"}},{"value":"Correction","order":3,"name":"change_type","label":"Change Type","group":{"name":"ChapterHistory","label":"Chapter History"}},{"value":"The corresponding author of the chapter informed that he realised the reference to Kennedy (2018) paper was not included in Figure 1 legend, which needs to be added for potential copyright reasons.","order":4,"name":"change_details","label":"Change Details","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}